Cargando…
Sequencing of Lp-PLA2-encoding PLA2G7 gene in 2000 Europeans reveals several rare loss-of-function mutations
Elevated plasma levels of lipoprotein-associated phospholipase A(2) (Lp-PLA2) activity have been shown to be associated with increased risk of coronary heart disease and an inhibitor of this enzyme is under development for the treatment of that condition. A Val279Phe null allele in this gene, that m...
Autores principales: | Song, K, Nelson, M R, Aponte, J, Manas, E S, Bacanu, S-A, Yuan, X, Kong, X, Cardon, L, Mooser, V E, Whittaker, J C, Waterworth, D M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449231/ https://www.ncbi.nlm.nih.gov/pubmed/21606947 http://dx.doi.org/10.1038/tpj.2011.20 |
Ejemplares similares
-
Carriage of the V279F Null Allele within the Gene Encoding Lp-PLA(2) Is Protective from Coronary Artery Disease in South Korean Males
por: Jang, Yangsoo, et al.
Publicado: (2011) -
Lp-PLA2 Inhibition—The Atherosclerosis Panacea?
por: Karakas, Mahir, et al.
Publicado: (2010) -
Genetic invalidation of Lp-PLA(2) as a therapeutic target: Large-scale study of five functional Lp-PLA(2)-lowering alleles
por: Gregson, John M, et al.
Publicado: (2016) -
Lp-PLA(2) Inhibitors for the Reduction of Cardiovascular Events
por: Steen, Dylan L., et al.
Publicado: (2013) -
Lp-PLA2 levels in HIV-infected patients
por: Díaz-Pollán, Beatriz, et al.
Publicado: (2014)